Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility to Support the Development of Personalized Therapeutics

LOS ANGELES: LOS ANGELES, July 15, 2021 /PRNewswire/ -- Generate Life Sciences (Generate) today announced the establishment of its Good Manufacturing Practice (GMP) facility in La Jolla, Calif. which will enable end-to-end manufacturing for newborn stem cell biologics. This facility will represent a big step in the evolution of Generate...

Click to view original post